-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2019 to Q2 2023.
- Arcutis Biotherapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$4.23M, a 168% decline year-over-year.
- Arcutis Biotherapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was -$14.6M, a 354% decline year-over-year.
- Arcutis Biotherapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$9.83M, a 5783% decline from 2021.
- Arcutis Biotherapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $173K, a 82.1% decline from 2020.
- Arcutis Biotherapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was $967K, a 14.9% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)